Use of monthly extended-release risperidone injection in schizophrenia: clinical experience

被引：0
|
作者：
de la Fuente Ruiz, E. [1 ,2 ]
Blasco Fresco, M. D. C. [1 ]
Alvarez Sanagustin, C. [3 ]
Duran Sandoval, L. T. [1 ]
机构：
[1] Hosp Univ Miguel Servet, Psychiat, Zaragoza, Spain
[2] Univ Zaragoza, Dept Med Psychiat & Dermatol, Zaragoza, Spain
[3] Hosp Univ Miguel Servet, Family & Community Med, Zaragoza, Spain
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
10.1192/j.eurpsy.2024.451
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0262
引用
收藏
页码：S210 / S210
页数：1
相关论文
共 50 条
  • [1] Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia
    Le Moigne, Anne
    Fava, Maurizio
    Csernansky, John
    Newcomer, John W.
    Graham, James
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (01) : 76 - 77
  • [2] Extended-release monthly buprenorphine injection
    Cuperfain, Ari B. B.
    Costa, Tianna
    Chopra, Nitin
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (01) : E14 - E14
  • [3] Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia Results From the Phase 3 Program
    Andorn, Anne
    Graham, Jay
    Csernansky, John
    Newcomer, John W.
    Shinde, Sunita
    Muma, Gilbert
    Heidbreder, Christian
    Fava, Maurizio
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (05) : 428 - 433
  • [4] Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone
    Canuso, Carla M.
    Youssef, Eriene A.
    Bossie, Cynthia A.
    Turkoz, Ibrahim
    Schreiner, Andreas
    Simpson, George M.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 209 - 215
  • [5] Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study
    Dhanda, Rahul
    Varghese, Della
    Nadipelli, Vijay R.
    Fava, Maurizio
    Joshi, Namita
    Solem, Caitlyn T.
    Graham, James A.
    Learned, Susan M.
    Heidbreder, Christian
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 1037 - 1050
  • [6] EFFICACY OF MONTHLY EXTENDED-RELEASE RISPERIDONE INJECTIONS (RBP-7000) FOR THE TREATMENT OF SCHIZOPHRENIA: AN ANALYSIS OF INDIVIDUAL PANSS ITEMS
    Andorn, Anne
    Graham, Jay
    Fava, Maurizio
    Csernansky, John
    Newcomer, John W.
    Walling, David
    Shinde, Sunita
    Muma, Gilbert
    Heidbreder, Christian
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S264 - S265
  • [7] Maintenance of Long-Term Clinical Stability in Patients With Schizophrenia Converted From Oral Antipsychotic Medications to Monthly Extended-Release Risperidone (RBP-7000)
    Graham, James
    Csernansky, John
    Fava, Maurizio
    Newcomer, John
    Andorn, Anne
    Shinde, Sunita
    Muma, Gilbert
    Heidbreder, Christian
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S175 - S176
  • [8] Long-Term Safety and Tolerability of a New Monthly Extended-Release Formulation of Risperidone (RBP-7000) in the Treatment of Subjects With Schizophrenia
    Graham, James
    Csernansky, John
    Fava, Maurizio
    Newcomer, John
    Andorn, Anne
    Shinde, Sunita
    Muma, Gilbert
    Heidbreder, Christian
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S430 - S431
  • [9] Use of extended-release niacin in clinical practice
    Suryadevara, Ramya S.
    Karas, Richard H.
    Kuvin, Jeffrey T.
    FUTURE LIPIDOLOGY, 2008, 3 (01): : 9 - 16
  • [10] PANSS Individual Item and Marder Dimension Analyses From a Pivotal Trial of RBP-7000 (Monthly Extended-Release Risperidone) in Schizophrenia Patients
    Le Moigne, Anne
    Csernansky, John
    Leadbetter, Robert A.
    Andorn, Anne C.
    Graham, James A.
    Heath, Amy T.
    Walling, David P.
    Newcomer, John W.
    Marder, Stephen R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (05)
12345